Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
BMC Palliat Care ; 16(1): 57, 2017 Nov 22.
Article in English | MEDLINE | ID: mdl-29166887

ABSTRACT

BACKGROUND: Little is known about ICU physicians' self-confidence and knowledge related to palliative care. Our objective was to investigate self-confidence and knowledge of German ICU physicians related to palliative care, and to assess the impact of work experience, gender, specialty and additional certifications in pain or palliative medicine. METHODS: In a multicentre prospective observational study ICU physicians of ten hospitals were asked to rate their self-confidence and to complete a multiple choice questionnaire for the assessment of knowledge. Beyond descriptive statistics and non-parametric tests for group comparisons, linear regression analysis was used to assess the impact of independent variable on self-confidence and knowledge. Spearman's rank test was calculated. RESULTS: 55% of answers in the knowledge test were correct and more than half of the participants rated themselves as "rather confident" or "confident". Linear regression analysis revealed that an additional certificate in either pain or palliative medicine significantly increased both knowledge and self-confidence, but only 15 out of 137 participants had at least one of those certificates. Relation between self-confidence and the results of the knowledge test was weak (r = 0.270 in female) and very weak (r = -0.007 in male). CONCLUSIONS: Although the questionnaire needs improvement according to the item analysis, it appears that, with respect to palliative care, ICU Physicians' self-confidence is not related to their knowledge. An additional certificate in either pain or palliative medicine was positively correlated to both self-confidence and knowledge. However, only a minority of the participants were qualified through such a certificate.


Subject(s)
Clinical Competence/standards , Intensive Care Units , Palliative Care/standards , Physicians/standards , Self Efficacy , Adult , Female , Humans , Intensive Care Units/organization & administration , Linear Models , Male , Middle Aged , Palliative Care/methods , Physicians/psychology , Practice Patterns, Physicians'/standards , Prospective Studies , Surveys and Questionnaires , Workforce
2.
Anesthesiology ; 127(2): 326-337, 2017 08.
Article in English | MEDLINE | ID: mdl-28459735

ABSTRACT

BACKGROUND: Situational awareness errors may play an important role in the genesis of patient harm. The authors examined closed anesthesia malpractice claims for death or brain damage to determine the frequency and type of situational awareness errors. METHODS: Surgical and procedural anesthesia death and brain damage claims in the Anesthesia Closed Claims Project database were analyzed. Situational awareness error was defined as failure to perceive relevant clinical information, failure to comprehend the meaning of available information, or failure to project, anticipate, or plan. Patient and case characteristics, primary damaging events, and anesthesia payments in claims with situational awareness errors were compared to other death and brain damage claims from 2002 to 2013. RESULTS: Anesthesiologist situational awareness errors contributed to death or brain damage in 198 of 266 claims (74%). Respiratory system damaging events were more common in claims with situational awareness errors (56%) than other claims (21%, P < 0.001). The most common specific respiratory events in error claims were inadequate oxygenation or ventilation (24%), difficult intubation (11%), and aspiration (10%). Payments were made in 85% of situational awareness error claims compared to 46% in other claims (P = 0.001), with no significant difference in payment size. Among 198 claims with anesthesia situational awareness error, perception errors were most common (42%), whereas comprehension errors (29%) and projection errors (29%) were relatively less common. CONCLUSIONS: Situational awareness error definitions were operationalized for reliable application to real-world anesthesia cases. Situational awareness errors may have contributed to catastrophic outcomes in three quarters of recent anesthesia malpractice claims.Situational awareness errors resulting in death or brain damage remain prevalent causes of malpractice claims in the 21st century.


Subject(s)
Anesthesia/adverse effects , Anesthesia/mortality , Awareness , Brain Injuries/chemically induced , Clinical Competence/statistics & numerical data , Insurance Claim Review/statistics & numerical data , Malpractice/statistics & numerical data , Brain Injuries/mortality , Databases, Factual/statistics & numerical data , Female , Humans , Male , Middle Aged
3.
Sleep Breath ; 21(3): 737-744, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28364198

ABSTRACT

BACKGROUND: Drug-induced sleep endoscopy (DISE) has become an important diagnostic examination tool in the treatment decision process for surgical therapies in the treatment of obstructive sleep apnea (OSA). Currently, there is a variety of regimes for the performance of DISE, which renders comparison and assessment across results difficult. It remains unclear how the different regimes influence the findings of the examination and the resulting conclusions and treatment recommendations. This study aimed to investigate the correlation between increasing levels of sedation (i.e., light, medium, and deep) induced by propofol using a target-controlled infusion (TCI) pump, with the obstruction patterns at the levels of the velum, oropharynx, tongue base, and epiglottis (i.e., VOTE classification). A second goal was the establishment of a sufficient sedation level to enable a reliable decision regarding treatment recommendations. MATERIAL AND METHODS: Forty-three patients with OSA underwent a DISE procedure using propofol TCI. Three levels of sedation were defined, depending on entropy levels and assessment of sedation: light sedation, medium sedation, and deep sedation. The evaluation of the upper airway at each level, with increasing sedation, was documented using the VOTE classification. The elapsed time at which each assessment was performed was recorded. RESULTS: Upper airway changes occurred and were measured throughout the DISE procedure. Clinically useful determinations of airway closure occurred at medium sedation; this level of sedation was most probably achieved with a blood propofol concentration of 3.2 µg/ml. In all 43 patients, definite treatment decisions could be made at medium sedation level. Increasing sedation did not result in changes in the treatment decision. CONCLUSIONS: Changes in upper airway collapse during DISE with propofol TCI occur at levels of medium sedation. Decisions regarding surgical treatment could be made at this level of sedation. CLINICAL TRIAL NAME: Upper Airway Collapse in Patients with Obstructive Sleep Apnea Syndrome by Drug Induced Sleep Endoscopy (URL: https://clinicaltrials.gov/ct2/results?term=NCT02588300&Search=Search ) REGISTRATION NUMBER: NCT02588300.


Subject(s)
Anesthesia/methods , Endoscopy/methods , Propofol/administration & dosage , Propofol/pharmacology , Sleep Apnea, Obstructive/therapy , Humans , Middle Aged , Prospective Studies , Sleep/drug effects
4.
PLoS One ; 12(3): e0173925, 2017.
Article in English | MEDLINE | ID: mdl-28291842

ABSTRACT

Although opioid-induced nausea and vomiting (OINV) is common and debilitating, its mechanism is still unclear. Recently, we suggested that opioids affect semicircular canal function and that this leads to a mismatch between canal input and other sensory information during head motion, which triggers OINV. Here, we assess if visual input is relevant for this mismatch. In a randomized-controlled crossover study 14 healthy men (26.9±3.4 years, mean±SD) were tested twice, once blindfolded and once with eyes open, with at least one-day washout. The opioid remifentanil was administered intravenously (0.15 µg/kg/min) for 60 minutes. After a thirty-minutes resting period, subjects' head and trunk were passively moved. Nausea was rated before remifentanil start (T0), before the movement intervention (T30) and after 60 minutes (T60) of administration. At rest (T0, T30), median nausea ratings were zero whether subjects were blindfolded or not. Movement triggered nausea independently of visual input (nausea rating 1.5/3.0 (median/interquartile range) in the blindfolded, 2.5/6 in the eyes-open condition, χ2(1) = 1.3, p = 0.25). As movement exacerbates OINV independently of visual input, a clash between visual and semicircular canal information is not the relevant trigger for OINV. To prevent OINV, emphasis should be put on head-rest, eye-closure is less important.


Subject(s)
Analgesics, Opioid/adverse effects , Nausea/prevention & control , Rest , Vomiting/prevention & control , Cross-Over Studies , Eye , Humans , Nausea/chemically induced , Vomiting/chemically induced
5.
BMC Anesthesiol ; 16(1): 90, 2016 10 10.
Article in English | MEDLINE | ID: mdl-27724859

ABSTRACT

BACKGROUND: The opioid remifentanil induces a decrease of vestibulo-ocular reflex function, which has been associated with nausea and vomiting when the subjects are moved. The study investigates in healthy female volunteers if immobility after remifentanil administration protects from nausea and vomiting. METHODS: In volunteers, a standardized movement intervention (a manually applied head-trunk movement forward, backward and sideward) was started 5 min (session A), 35 min (session B) or 60 min (session C) after cessation of a remifentanil infusion (0.15 µg · kg-1 · min-1). In a cross-over design, 16 participants were randomized to the early (sessions A and B) or the late intervention group (sessions A and C). Nausea was assessed using a 11-point numerical rating scale before and after each movement intervention. Differences within and between groups were assessed with non-parametric tests for paired and unpaired data. RESULTS: Comparing sessions A, B and C, intensity of nausea was time-dependent after cessation of remifentanil administration (p = 0.015). In the early intervention group, nausea decreased from median 5.0 [IQR 1.5;6.0] in session A to 2.0 [1.0;3.0] in session B (p = 0.094); in the late intervention group nausea decreased from 3.5 [2.0;5.0] in session A to 0.5 [0.0;2.0] in session C (p = 0.031). CONCLUSIONS: In summary, in young healthy women, immobility after remifentanil administration protects from nausea and vomiting in a time-dependent manner. In analogy to motion sickness, opioid-induced nausea and vomiting in female volunteers can be triggered by movement. TRIAL REGISTRATION: German Clinical Trials Register DRKS00010667 . The trial was registered retrospectively on June, 20th 2016.


Subject(s)
Analgesics, Opioid/administration & dosage , Immobilization/methods , Piperidines/administration & dosage , Postoperative Nausea and Vomiting/prevention & control , Adult , Analgesics, Opioid/adverse effects , Cross-Over Studies , Female , Head Movements , Humans , Piperidines/adverse effects , Reflex, Vestibulo-Ocular/drug effects , Remifentanil , Time Factors , Young Adult
6.
BMC Anesthesiol ; 16: 4, 2016 Jan 16.
Article in English | MEDLINE | ID: mdl-26772179

ABSTRACT

BACKGROUND: A loss of adequate Situation Awareness (SA) may play a major role in the genesis of critical incidents in anesthesia and critical care. This observational study aimed to determine the frequency of SA errors in cases of a critical incident reporting system (CIRS). METHODS: Two experts independently reviewed 200 cases from the German Anesthesia CIRS. For inclusion, reports had to be related to anesthesia or critical care for an individual patient and take place in an in-hospital setting. Based on the SA framework, the frequency of SA errors was determined. Representative cases were analyzed qualitatively to illustrate the role of SA for decision-making. RESULTS: SA errors were identified in 81.5%. Predominantly, errors occurred on the levels of perception (38.0%) and comprehension (31.5%). Errors on the level of projection played a minor role (12.0%). The qualitative analysis of selected cases illustrates the crucial role of SA for decision-making and performance. CONCLUSIONS: SA errors are very frequent in critical incidents reported in a CIRS. The SA taxonomy was suitable to provide mechanistic insights into the central role of SA for decision-making and thus, patient safety.


Subject(s)
Anesthesia/adverse effects , Anesthesia/standards , Awareness , Critical Care/standards , Medical Errors/adverse effects , Risk Management/standards , Anesthesia/methods , Critical Care/methods , Germany , Humans , Medical Errors/prevention & control , Risk Management/methods
7.
PLoS One ; 10(8): e0135263, 2015.
Article in English | MEDLINE | ID: mdl-26313751

ABSTRACT

BACKGROUND AND AIMS: Opioids are indispensable for pain treatment but may cause serious nausea and vomiting. The mechanism leading to these complications is not clear. We investigated whether an opioid effect on the vestibular system resulting in corrupt head motion sensation is causative and, consequently, whether head-rest prevents nausea. METHODS: Thirty-six healthy men (26.6 ± 4.3 years) received an opioid remifentanil infusion (45 min, 0.15 µg/kg/min). Outcome measures were the vestibulo-ocular reflex (VOR) gain determined by video-head-impulse-testing, and nausea. The first experiment (n = 10) assessed outcome measures at rest and after a series of five 1-Hz forward and backward head-trunk movements during one-time remifentanil administration. The second experiment (n = 10) determined outcome measures on two days in a controlled crossover design: (1) without movement and (2) with a series of five 1-Hz forward and backward head-trunk bends 30 min after remifentanil start. Nausea was psychophysically quantified (scale from 0 to 10). The third controlled crossover experiment (n = 16) assessed nausea (1) without movement and (2) with head movement; isolated head movements consisting of the three axes of rotation (pitch, roll, yaw) were imposed 20 times at a frequency of 1 Hz in a random, unpredictable order of each of the three axes. All movements were applied manually, passively with amplitudes of about ± 45 degrees. RESULTS: The VOR gain decreased during remifentanil administration (p<0.001), averaging 0.92 ± 0.05 (mean ± standard deviation) before, 0.60 ± 0.12 with, and 0.91 ± 0.05 after infusion. The average half-life of VOR recovery was 5.3 ± 2.4 min. 32/36 subjects had no nausea at rest (nausea scale 0.00/0.00 median/interquartile range). Head-trunk and isolated head movement triggered nausea in 64% (p<0.01) with no difference between head-trunk and isolated head movements (nausea scale 4.00/7.25 and 1.00/4.5, respectively). CONCLUSIONS: Remifentanil reversibly decreases VOR gain at a half-life reflecting the drug's pharmacokinetics. We suggest that the decrease in VOR gain leads to a perceptual mismatch of multisensory input with the applied head movement, which results in nausea, and that, consequently, vigorous head movements should be avoided to prevent opioid-induced nausea.


Subject(s)
Analgesics, Opioid/adverse effects , Nausea/chemically induced , Piperidines/adverse effects , Reflex, Vestibulo-Ocular/drug effects , Adult , Head Movements/physiology , Humans , Male , Nausea/prevention & control , Remifentanil
8.
Prehosp Disaster Med ; 29(2): 176-82, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24650543

ABSTRACT

High-fidelity simulators (HFSs) have been shown to prompt critical actions at a level equal to that of trained human actors (HAs) and increase perceived realism in intrahospital mass-casualty incident (MCI) exercises. For unannounced prehospital MCI exercises, however, no data are available about the feasibility of incorporating HFSs. This case report describes the integration of HFSs in such an unannounced prehospital MCI drill with HAs and provides data about the differences concerning triage, treatment, and transport of HFSs and HAs with identical injury patterns. For this purpose, 75 actors and four high-fidelity simulators were subdivided into nine groups defined by a specific injury pattern. Four HFSs and six HAs comprised a group suffering from traumatic brain injury and blunt abdominal trauma. Triage results, times for transport, and number of diagnostic and therapeutic tasks were recorded. Means were compared by t test or one-way ANOVA. Triage times and results did not differ between actors and simulators. The number of diagnostic (1.25, SD = 0.5 in simulators vs 3.5, SD = 1.05 in HAs; P = .010) and therapeutic tasks (2.0, SD = 1.6 in simulators vs 4.8, SD = 0.4 in HAs; P = .019) were significantly lower in simulators. Due to difficulties in treating and evacuating the casualties from the site of the accident in a timely manner, all simulators died. Possible causal factors and strategies are discussed, with the aim of increasing the utility of simulators in emergency medicine training.


Subject(s)
Abdominal Injuries/therapy , Brain Injuries/therapy , Emergency Medical Services/organization & administration , Emergency Medicine/education , Mass Casualty Incidents , Patient Simulation , Wounds, Nonpenetrating/therapy , Disaster Planning , Humans , Transportation of Patients , Triage
9.
J Clin Monit Comput ; 28(5): 475-80, 2014 Oct.
Article in English | MEDLINE | ID: mdl-23471595

ABSTRACT

Development of accurate Situation Awareness (SA) depends on experience and may be impaired during excessive workload. In order to gain adequate SA for decision making and performance, anaesthetists need to distribute visual attention effectively. Therefore, we hypothesized that in more experienced anaesthetists performance is better and increase of physiological workload is less during critical incidents. Additionally, we investigated the relation between physiological workload indicators and distribution of visual attention. In fifteen anaesthetists, the increase of pupil size and heart rate was assessed in course of a simulated critical incident. Simulator log files were used for performance assessment. An eye-tracking device (EyeSeeCam) provided data about the anaesthetists' distribution of visual attention. Performance was assessed as time until definitive treatment. T tests and multivariate generalized linear models (MANOVA) were used for retrospective statistical analysis. Mean pupil diameter increase was 8.1% (SD ± 4.3) in the less experienced and 15.8% (±10.4) in the more experienced subjects (p = 0.191). Mean heart rate increase was 10.2% (±6.7) and 10.5% (±8.3, p = 0.956), respectively. Performance did not depend on experience. Pupil diameter and heart rate increases were associated with a shift of visual attention from monitoring towards manual tasks (not significant). For the first time, the following four variables were assessed simultaneously: physiological workload indicators, performance, experience, and distribution of visual attention between "monitoring" and "manual" tasks. However, we were unable to detect significant interactions between these variables. This experimental model could prove valuable in the investigation of gaining and maintaining SA in the operation theatre.


Subject(s)
Anesthesiology , Attention , Workload , Anaphylaxis/physiopathology , Anaphylaxis/therapy , Anesthesia, General , Clinical Competence , Computer Simulation , Eye Movement Measurements , Humans , Medical Informatics , Monitoring, Physiologic , Operating Rooms , Retrospective Studies , Task Performance and Analysis , Visual Perception
10.
Anesthesiology ; 118(3): 729-42, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23291626

ABSTRACT

Accurate situation awareness (SA) of medical staff is integral for providing optimal performance during the treatment of patients. An understanding of SA and how it affects treatment of patients is therefore crucial for patient safety and an essential element for research on human factors in anesthesia. This review describes the concept of SA in the anesthesia environment, including the interaction with associated medical teams. Different approaches for its assessment in the work environment of anesthesia are provided. Factors contributing to expertise in SA are described and approaches for the training of SA in anesthesia are discussed, as are types of errors that occur during the development of SA. Finally, the authors briefly present strategies to improve SA during daily anesthesia practice through altered designs of monitor displays.


Subject(s)
Anaphylaxis/chemically induced , Anaphylaxis/diagnosis , Anesthesia/adverse effects , Awareness , Clinical Competence/standards , Aged , Anaphylaxis/physiopathology , Biomedical Research/standards , Humans , Male
11.
J Nucl Med ; 51(7): 1030-5, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20554735

ABSTRACT

UNLABELLED: Essential tremor is the most common movement disorder, but the underlying pathophysiology is not well understood. A primary overactivity of cerebellothalamic output pathways is the most conspicuous finding, as indicated by animal and human studies. It has been argued that this overactivity may be due to impaired central inhibition, and converging evidence points toward a potential role of gamma-aminobutyric acid (GABA) dysfunction in tremor generation. METHODS: Using (11)C-flumazenil and PET, we calculated the distribution volume, an index of availability of benzodiazepine receptor sites of the GABA(A) complex, in a group of 8 patients with bilateral essential tremor, as compared with 11 healthy controls. RESULTS: Significant increases in binding of (11)C-flumazenil at the benzodiazepine receptor site of the GABA(A) receptor in the cerebellum, the ventrolateral thalamus, and the lateral premotor cortex were identified in the essential tremor group. CONCLUSION: Essential tremor is associated with reduced GABAergic function and increased availability of benzodiazepine receptor sites in brain regions implicated specifically in tremor genesis. This finding is thought to reflect overactivity of cerebellothalamic circuits and, hence, lends support to the "GABA hypothesis" of essential tremor.


Subject(s)
Brain/diagnostic imaging , Essential Tremor/diagnostic imaging , Flumazenil , GABA Modulators , Radiopharmaceuticals , gamma-Aminobutyric Acid/physiology , Aged , Cerebellum/diagnostic imaging , Female , Flumazenil/chemical synthesis , GABA Modulators/chemical synthesis , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Motor Cortex/diagnostic imaging , Neural Pathways/diagnostic imaging , Positron-Emission Tomography , Radiopharmaceuticals/chemical synthesis , Receptors, GABA-A/metabolism , Receptors, GABA-A/physiology , Thalamus/diagnostic imaging
12.
Eur J Nucl Med Mol Imaging ; 36(4): 659-70, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19043703

ABSTRACT

PURPOSE: [(11)C]Flumazenil (FMZ) is a benzodiazepine receptor antagonist that binds reversibly to central-type gamma-aminobutyric acid (GABA-A) sites. A validated approach for analysis of [(11)C]FMZ is the invasive one-tissue (1T) compartmental model. However, it would be advantageous to analyse FMZ binding with whole-brain pixel-based methods that do not require a-priori hypotheses regarding preselected regions. Therefore, in this study we compared invasive and noninvasive data-driven methods (Logan graphical analysis, LGA; multilinear reference tissue model, MRTM2; spectral analysis, SA; basis pursuit denoising, BPD) with the 1T model. METHODS: We focused on two aspects: (1) replacing the arterial input function analyses with a reference tissue method using the pons as the reference tissue, and (2) shortening the scan protocol from 90 min to 60 min. Dynamic PET scans were conducted in seven healthy volunteers with arterial blood sampling. Distribution volume ratios (DVRs) were selected as the common outcome measure. RESULTS: The SA, LGA with and without arterial input, and MRTM2 agreed best with the 1T model DVR values. The invasive and noninvasive BPD were slightly less well correlated. The full protocol of a 90-min emission data performed better than the 60-min protocol, but the 60-min protocol still delivered useful data, as assessed by the coefficient of variation, and the correlation and bias analyses. CONCLUSION: This study showed that the SA, LGA and MRTM2 are valid methods for the quantification of benzodiazepine receptor binding with [(11)C]FMZ using an invasive or noninvasive protocol, and therefore have the potential to reduce the invasiveness of the procedure.


Subject(s)
Brain/diagnostic imaging , Chemistry, Pharmaceutical/methods , Flumazenil/chemistry , Flumazenil/pharmacology , GABA Modulators/pharmacology , Positron-Emission Tomography/methods , Brain/pathology , Female , Fluorodeoxyglucose F18/pharmacology , Humans , Kinetics , Magnetic Resonance Imaging/methods , Male , Middle Aged , Radiopharmaceuticals/pharmacology , Receptors, GABA-A/chemistry , Time Factors
13.
Cereb Cortex ; 18(11): 2523-31, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18296435

ABSTRACT

The runner's high describes a euphoric state resulting from long-distance running. The cerebral neurochemical correlates of exercise-induced mood changes have been barely investigated so far. We aimed to unravel the opioidergic mechanisms of the runner's high in the human brain and to identify the relationship to perceived euphoria. We performed a positron emission tomography "ligand activation" study with the nonselective opioidergic ligand 6-O-(2-[(18)F]fluoroethyl)-6-O-desmethyldiprenorphine ([(18)F]FDPN). Ten athletes were scanned at 2 separate occasions in random order, at rest and after 2 h of endurance running (21.5 +/- 4.7 km). Binding kinetics of [(18)F]FDPN were quantified by basis pursuit denoising (DEPICT software). Statistical parametric mapping (SPM2) was used for voxelwise analyses to determine relative changes in ligand binding after running and correlations of opioid binding with euphoria ratings. Reductions in opioid receptor availability were identified preferentially in prefrontal and limbic/paralimbic brain structures. The level of euphoria was significantly increased after running and was inversely correlated with opioid binding in prefrontal/orbitofrontal cortices, the anterior cingulate cortex, bilateral insula, parainsular cortex, and temporoparietal regions. These findings support the "opioid theory" of the runner's high and suggest region-specific effects in frontolimbic brain areas that are involved in the processing of affective states and mood.


Subject(s)
Euphoria/physiology , Limbic System/physiology , Opioid Peptides/physiology , Prefrontal Cortex/physiology , Running/physiology , Adult , Diprenorphine/analogs & derivatives , Exercise/physiology , Exercise/psychology , Humans , Limbic System/diagnostic imaging , Male , Physical Endurance/physiology , Pilot Projects , Positron-Emission Tomography , Prefrontal Cortex/diagnostic imaging , Running/psychology
14.
Anesthesiology ; 106(3): 548-56, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17325514

ABSTRACT

BACKGROUND: Previous imaging studies have demonstrated a number of cortical and subcortical brain structures to be activated during noxious stimulation and infusion of narcotic analgesics. This study used O-water and positron emission tomography to investigate dose-dependent effects of the short-acting mu-selective opioid agonist remifentanil on regional cerebral blood flow during experimentally induced painful heat stimulation in healthy male volunteers. METHODS: Positron emission tomography measurements were performed with injection of 7 mCi O-water during nonpainful heat and painful heat stimulation of the volar forearm. Three experimental conditions were used during both sensory stimuli: saline, 0.05 microg x kg x min remifentanil, and 0.15 microg x kg x min remifentanil. Cardiovascular and respiratory parameters were monitored noninvasively. Across the three conditions, dose-dependent effects of remifentanil on regional cerebral blood flow were analyzed on a pixel-wise basis using a statistical parametric mapping approach. RESULTS: During saline infusion, regional cerebral blood flow increased in response to noxious thermal stimulation in a number of brain regions as previously reported. There was a reduction in pain-related activations with increasing doses of remifentanil in the thalamus, insula, and anterior and posterior cingulate cortex. Increasing activation occurred in the cingulofrontal cortex (including the perigenual anterior cingulate cortex) and the periaqueductal gray. CONCLUSIONS: Remifentanil induced regional cerebral blood flow increases in the cingulofrontal cortex and periaqueductal gray during pain stimulation, indicating that mu-opioidergic activation modulates activity in pain inhibitory circuitries. This provides direct evidence that opioidergic analgesia is mediated by activation of established descending antinociceptive pathways.


Subject(s)
Analgesics, Opioid/pharmacology , Brain/diagnostic imaging , Cerebrovascular Circulation/drug effects , Pain/drug therapy , Piperidines/pharmacology , Adult , Blood Gas Analysis/methods , Blood Pressure/drug effects , Brain/physiopathology , Brain Mapping/methods , Dose-Response Relationship, Drug , Heart Rate/drug effects , Hot Temperature , Humans , Male , Pain/physiopathology , Pain Measurement/drug effects , Physical Stimulation/methods , Positron-Emission Tomography/methods , Reference Values , Remifentanil , Sodium Chloride/administration & dosage
15.
Anesth Analg ; 103(3): 729-37, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16931688

ABSTRACT

Little is known about the effects of low-dose S-(+)-ketamine on the cerebral processing of pain. We investigated the effects of subanesthetic IV S-(+)-ketamine doses on the perception of experimental painful heat stimuli. Healthy volunteers were evaluated with functional magnetic resonance imaging (fMRI) while receiving the painful stimuli in conjunction with placebo and increasing doses (0.05, 0.1, 0.15 mg x kg(-1) x h(-1)) of ketamine infusion. Vital variables were monitored and all subjects rated pain intensity and unpleasantness on a numerical rating scale. Alterations in consciousness were measured using a psycho-behavioral questionnaire. Pain unpleasantness declined as ketamine dosage was increased (55.1% decrease, placebo versus 0.15 mg x kg(-1) x h(-1) ketamine). Pain intensity ratings also decreased with increasing ketamine dosage but to a lesser extent (23.1% decrease). During placebo administration, a typical pain activation network (thalamus, insula, cingulate, and prefrontal cortex) was found, whereas decreased pain perception with ketamine was associated with a dose-dependent reduction of pain-induced cerebral activations. Analysis of the dose-dependent ketamine effects on pain processing showed a decreasing activation of the secondary somatosensory cortex (S2), insula and anterior cingulate cortex. This part of the anterior cingulate cortex (midcingulate cortex) has been linked with the affective pain component that underlines the potency of ketamine in modulating affective pain processing.


Subject(s)
Brain/drug effects , Ketamine/pharmacology , Magnetic Resonance Imaging/instrumentation , Magnetic Resonance Imaging/methods , Pain/drug therapy , Adult , Analgesics/pharmacology , Brain/pathology , Dose-Response Relationship, Drug , Hemodynamics , Humans , Male , Pain Measurement , Pilot Projects , Placebos
16.
Pain ; 122(1-2): 63-7, 2006 May.
Article in English | MEDLINE | ID: mdl-16527398

ABSTRACT

Opioids modulate the affective component of pain and in vivo data indicate that opioids induce activation changes in the rostral ACC, insula and other brain areas. Hence, opioidergic release is to be expected in these brain regions following experimental pain stimulation. We examined healthy volunteers during heat pain and control subjects during rest using [18F]fluorodiprenorphine-PET. Pain stimulation led to significant reduction of diprenorphine binding in limbic and paralimbic brain areas including the rostral ACC and insula. The finding of altered opioidergic receptor availability in the rostral ACC after experimental nociceptive pain is novel and provides direct evidence for the involvement of this region in endogenous opioidergic inhibition of pain.


Subject(s)
Brain/diagnostic imaging , Brain/metabolism , Diprenorphine/analogs & derivatives , Hot Temperature/adverse effects , Narcotics/metabolism , Synaptic Transmission , Adult , Brain Mapping/methods , Diprenorphine/pharmacokinetics , Female , Humans , Hyperalgesia/etiology , Male , Middle Aged , Neurotransmitter Agents/metabolism , Radionuclide Imaging , Radiopharmaceuticals/pharmacokinetics , Receptors, Opioid/metabolism , Tissue Distribution
17.
CNS Drugs ; 19(9): 745-58, 2005.
Article in English | MEDLINE | ID: mdl-16142990

ABSTRACT

Electroconvulsive therapy (ECT) is used in the treatment of severe psychiatric disorders. It involves the induction of a seizure for therapeutic purposes by the administration of a variable-frequency electrical stimulus via electrodes applied to the scalp. The original application of ECT in non-anaesthetised patients resulted in many traumatic effects and was replaced, in the early 1960s, with a modified ECT regimen that used anaesthesia with neuromuscular blockade. This remains the worldwide standard today. The development of modern ECT devices, with improved impulse modes, has also reduced the incidence of post-interventional cognitive adverse effects. The variety of centrally-acting co-medications administered and the cardiovascular effects occurring during the procedure make patients receiving ECT a challenge for the anaesthetist. The efficacy of ECT depends on the production of adequate seizures; however, the anaesthetic agents commonly used during ECT suppress the generation of convulsions. Therefore, the efficacy of ECT requires knowledge of anaesthetic precepts, understanding of the interaction between anaesthetic drugs and seizure activity, and awareness of the physiological effects of ECT as well as the treatment of those effects. Successful and safe ECT depends on the correct choice of anaesthetic drugs for the individual patient, which have to be chosen with respect to the individual concomitant medication and pre-existing diseases. This review provides information for the optimal selection, set-up and practice of anaesthetic drug treatment in ECT.


Subject(s)
Anesthetics/therapeutic use , Electroconvulsive Therapy/adverse effects , Pain/drug therapy , Psychotic Disorders/therapy , Animals , Humans , Pain/etiology , Psychotic Disorders/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...